Catalyst Pharmaceuticals Correlations

CPRX Stock  USD 22.34  0.41  1.87%   
The current 90-days correlation between Catalyst Pharmaceuticals and Enliven Therapeutics is 0.32 (i.e., Weak diversification). The correlation of Catalyst Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Catalyst Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Catalyst Pharmaceuticals and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalyst Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

Moving together with Catalyst Stock

  0.69ESPR Esperion TherapeuticsPairCorr
  0.74EWTX Edgewise TherapeuticsPairCorr
  0.68BHC Bausch Health CompaniesPairCorr
  0.66BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.7EBS Emergent BiosolutionsPairCorr
  0.87GILD Gilead SciencesPairCorr
  0.76MNMD Mind MedicinePairCorr

Moving against Catalyst Stock

  0.72HLN Haleon plcPairCorr
  0.7MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.68TAK Takeda PharmaceuticalPairCorr
  0.66ZTS Zoetis IncPairCorr
  0.58JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.58RDY Dr Reddys LaboratoriesPairCorr
  0.55LLY Eli Lilly Sell-off TrendPairCorr
  0.53ELAN Elanco Animal Health Potential GrowthPairCorr
  0.5PFE Pfizer Inc Aggressive PushPairCorr
  0.69ANRO Alto Neuroscience,PairCorr
  0.44CTLT CatalentPairCorr
  0.39ANEB Anebulo PharmaceuticalsPairCorr
  0.37LTRN Lantern PharmaPairCorr
  0.35DRMAW Dermata TherapeuticsPairCorr
  0.35AMGN Amgen IncPairCorr
  0.31CVS CVS Health Corp Aggressive PushPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ELVNCUE
ELYMTFFP
INBXTFFP
MOLNCUE
INBXELYM
MOLNELVN
  
High negative correlations   
ELYMCUE
ELVNELYM
MOLNELYM
MOLNINBX
TFFPCUE
MOLNTFFP

Risk-Adjusted Indicators

There is a big difference between Catalyst Stock performing well and Catalyst Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Catalyst Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Catalyst Pharmaceuticals Corporate Management

Philip SchwartzCo SecProfile
CMA CPAVP, OfficerProfile
Pete SrVice SalesProfile
Mary ColemanVP RelationsProfile
Stanley MDSenior DiscoveryProfile
Gary MDChief OfficerProfile